Table 2.
Control group (N=6) | Intervention group (N=6) | |||
---|---|---|---|---|
Week 0 (Visit 1) | Week 4 (Visit 2) | Week 0 (Visit 1) | Week 4 (Visit 2) | |
LAD (cm) | 3.28 ± 0.15 | 3.32 ± 0.12 | 3.28 ± 0.10 | 3.37 ± 0.07 |
IVSD (cm) | 0.98 ± 0.07 | 1.01 ± 0.06 | 1.07 ± 0.03 | 1.05 ± 0.03 |
LVDD (cm) | 5.17 ± 0.13 | 5.08 ± 0.10 | 5.29 ± 0.08 | 5.13 ± 0.07 |
LVPW (cm) | 1.04 ± 0.04 | 1.10 ± 0.03 | 1.07 ± 0.06 | 1.11 ± 0.03 |
LV Mass (g) | 206.50 ± 12.19 | 205.83 ± 12.53 | 222.77 ± 9.52 | 213.62 ± 2.99 |
FS (%) | 37.00 ± 2.37 | 35.83 ± 1.49 | 33.55 ± 1.04 | 32.49 ± 1.63 |
EF (%) | 74.67 ± 3.04 | 74.00 ± 1.46 | 69.17 ± 3.15 | 66.83 ± 2.63 |
SV (ml) | 103.33 ± 7.36 | 97.67 ± 3.94 | 111.18 ± 6.59 | 89.08 ± 6.51** |
CO (L/min) | 7.38 ± 0.62 | 6.81 ± 0.47 | 7.29 ± 0.60 | 5.40 ± 0.43** |
E (cm) | 97.17 ± 5.92 | 100.17 ± 4.94 | 108.83 ± 4.80 | 105.17 ± 4.35 |
A (cm) | 49.33 ± 3.59 | 50.67 ± 2.87 | 52.67 ± 4.81 | 44.33 ± 3.87 |
E/A | 2.04 ± 0.25 | 2.02 ± 0.19 | 2.14 ± 0.20 | 2.47 ± 0.23 |
Values are means ± SE, LAD= left atrial end-systolic dimension; IVSD= interventricular septum dimension; LVDD= left ventricular diastolic diameter; LVPW=left ventricular posterior wall dimension; LV mass= left ventricular mass. FS= fractional shortening; EF= ejection fraction; SV= stroke volume; CO=cardiac output; E=early diastolic mitral flow; A=late diastolic mitral flow.
P< 0.05,
P< 0.01 week 0 vs. week 4.